Testing an antibiotic for children with bacterial infections
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a single dose of an investigational antibiotic called gepotidacin in children aged 2 to 12 who have a bacterial infection or are taking antibiotics to prevent one. The goal is to see how the medicine works in young patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 2 and 12 years old and weigh at least 22 pounds (10 kilograms).
- Be currently taking antibiotics for a confirmed or suspected bacterial infection, or taking antibiotics to prevent infection.
- Be staying in a hospital or overnight clinic for at least 24 hours after receiving the study medicine.
- Have a small tube (IV) already placed in a vein for standard care.
- If female and able to become pregnant, must have a negative pregnancy test before starting.
- Parent or guardian must understand and sign a consent form, and the child must agree to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures how much of an antibiotic called gepotidacin passes into breast milk. Researchers will give healthy breastfeeding women a single dose and collect milk samples to understand if it's safe for nursing infants.
This trial tests whether fosfomycin works better than the usual treatment for children with urine infections caused by antibiotic-resistant germs. It may help by using an antibiotic choice that can still work when common oral options may fail.
This Phase 2 trial tests LBP-EC01 to treat a bladder infection (UTI) caused by drug-resistant E. coli. It may help by targeting the specific bacteria that make UTIs harder to cure with common antibiotics.
This study tests a new antibiotic for children with difficult-to-treat urinary tract infections (UTIs). The medicine is given through an IV and may help when other antibiotics haven't worked.
This trial tests an oral antibiotic called sulopenem for teenagers (12 to under 18) who have a bacterial infection. It checks how the drug works in the body and may offer a new treatment option.
This study tests whether shorter courses of antibiotics are as effective as longer ones for children hospitalized with pneumonia, skin infections, or urinary tract infections. It may help children get back to normal faster and reduce side effects.
Hear when a new Urinary Tract Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.